Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "FDA"
Home
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical trial for SynKIR-310—a...
07/26/2026, 08:54 ET
Shifting the Burden: Why South Korea’s OB-GYNs Reject 'Discretion' on Abortion Pills
The South Korean government's proposal to leave the prescription of abortion medication up to the professional discretion of individual physicians is...
07/19/2026, 05:48 ET
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production
GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
07/17/2026, 06:46 ET
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch
Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
07/14/2026, 08:19 ET
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
07/12/2026, 06:48 ET
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
07/12/2026, 01:39 ET
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
07/12/2026, 01:37 ET
Why Do Properly Repaired Shoulder Tendons Tear Again? The Answer Lies in Tissue 'Quality'
A man in his mid-50s, identified as Mr. A, underwent rotator cuff repair surgery to alleviate debilitating shoulder...
06/27/2026, 01:47 ET
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
06/15/2026, 09:10 ET
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder
Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
06/07/2026, 18:28 ET
Previous
1
2
3
4
5
Next